4.5 Article

Prediction of complications of type 2 Diabetes: A Machine learning approach

期刊

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2022.110013

关键词

Diabetes complications; Machine learning; Artificial intelligence; Predictive models; Clinical inertia; Quality of care

资金

  1. METEDA s.r.l. (Rome, Italy) [153, 30/9/2019]
  2. Universit`a Politecnica delle Marche (Ancona, Italy)
  3. Astra-Zeneca
  4. NovoNordisk
  5. Shionogi
  6. Theras
  7. Astra Zeneca
  8. Eli Lilly
  9. Boehringer
  10. Associazione Medici Diabetologi (AMD)

向作者/读者索取更多资源

This study constructed predictive models of diabetes complications using big data machine learning and demonstrated their accuracy and sensitivity through validation.
Aim: To construct predictive models of diabetes complications (DCs) by big data machine learning, based on electronic medical records.Methods: Six groups of DCs were considered: eye complications, cardiovascular, cerebrovascular, and peripheral vascular disease, nephropathy, diabetic neuropathy. A supervised, tree-based learning approach (XGBoost) was used to predict the onset of each complication within 5 years (task 1). Furthermore, a separate prediction for early (within 2 years) and late (3-5 years) onset of complication (task 2) was performed. A dataset of 147.664 patients seen during 15 years by 23 centers was used. External validation was performed in five additional centers. Models were evaluated by considering accuracy, sensitivity, specificity, and area under the ROC curve (AUC).Results: For all DCs considered, the predictive models in task 1 showed an accuracy > 70 %, and AUC largely exceeded 0.80, reaching 0.97 for nephropathy. For task 2, all predictive models showed an accuracy > 70 % and an AUC > 0.85. Sensitivity in predicting the early occurrence of the complication ranged between 83.2 % (peripheral vascular disease) and 88.5 % (nephropathy).Conclusions: Machine learning approach offers the opportunity to identify patients at greater risk of complica-tions. This can help overcoming clinical inertia and improving the quality of diabetes care.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据